Internal Medicine · Los Angeles, CA
NPI
1285732370
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
266 S Harvard Blvd Ste 110
Los Angeles, CA, 90004
Phone (213) 388-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$363K
6,568 services
Medicare patients, 2024
770
Average age 82
Drug cost, 2024
$6.8M
44,269 prescriptions
Company payments, 2025
$2,358
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sang H Baik was code 99213 (office e&m - established), 1,406 times for 519 patients. In total Sang H Baik billed 6,568 services in 22 codes, and Medicare paid $363K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,406 | 519 | $75.88 | $107K |
| 36415 Venipuncture Blood Collection | Office | 1,279 | 642 | $8.65 | $11K |
| 99214 Office E&M - Established | Office | 1,134 | 564 | $104.93 | $119K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 520 | 520 | $140.53 | $73K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 481 | 481 | $21.14 | $10K |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 457 | 455 | $13.72 | $6,271 |
| 82962 Clinical Chemistry | Office | 389 | 171 | $3.21 | $1,249 |
| G0008 Administration of influenza virus vaccine | Office | 315 | 314 | $35.02 | $11K |
| 90661 Vaccine Product | Office | 248 | 248 | $36.11 | $8,955 |
| 96372 Injection Administration | Office | 106 | 68 | $11.84 | $1,255 |
| 90653 Vaccine Product | Office | 67 | 67 | $81.82 | $5,482 |
| 99212 Office E&M - Established | Office | 56 | 52 | $45.71 | $2,560 |
| 99441 Telephone Services | Office | 24 | 17 | $49.20 | $1,181 |
| 93000 Electrocardiogram | Office | 23 | 21 | $12.44 | $286 |
| 99442 Telephone Services | Office | 22 | 19 | $78.19 | $1,720 |
By year: 2022 $702K for 9,667 services; 2023 $426K for 7,017 services; 2024 $363K for 6,568 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,279 | 642 | $8.65 | $11K |
| 82962 Clinical Chemistry | 389 | 171 | $3.21 | $1,249 |
Medicare prescription drug claims, 2024
In 2024, the drug Sang H Baik prescribed most often to Medicare patients was Atorvastatin Calcium, with 3,307 prescriptions and refills. In total Sang H Baik wrote 44,269 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 3,307 | 7,548 | 843 | $17K |
| Vascepa Icosapent Ethyl | 2,098 | 2,937 | 396 | $740K |
| Amlodipine Besylate Generic | 2,087 | 4,591 | 511 | $4,612 |
| Losartan Potassium Generic | 1,861 | 4,324 | 488 | $8,716 |
| Omeprazole Generic | 1,223 | 2,332 | 324 | $6,160 |
| Creon Lipase/Protease/Amylase | 1,124 | 1,310 | 272 | $1.0M |
| Lidocaine Generic | 1,104 | 1,853 | 282 | $165K |
| Metoprolol Succinate Generic | 1,005 | 2,028 | 227 | $6,975 |
| Donepezil Hcl Generic | 877 | 1,640 | 190 | $3,359 |
| Levothyroxine Sodium Generic | 843 | 1,826 | 194 | $7,943 |
| Metformin Hcl Generic | 823 | 1,947 | 227 | $3,499 |
| Pantoprazole Sodium Generic | 746 | 1,457 | 211 | $4,441 |
| Farxiga Dapagliflozin Propanediol | 728 | 978 | 143 | $544K |
| Tamsulosin Hcl Generic | 709 | 1,587 | 187 | $4,702 |
| Rosuvastatin Calcium Generic | 691 | 1,563 | 181 | $4,141 |
Brand drugs: 10,169 claims; generic drugs: 33,821 claims; opioid claims: 209.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sang H Baik $2,358 ($2,358 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $307.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $307 |
| Ardelyx, Inc. ARDX | 9 | $284 |
| GlaxoSmithKline, LLC. GSK | 16 | $281 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $205 |
| Abbvie Inc. ABBV | 7 | $186 |
| Lilly USA, LLC LLY | 8 | $183 |
| Sumitomo Pharma America, Inc. 4506.T | 8 | $160 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $99.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.